Abstract:Wei Ye, 1, &ast Junwen Lu, 1, &ast Zuxian Yang, 2 Ben Yang, 2 Guanya Zhu, 2 Chunli Xue 2 1 Department of Burn Surgery, the First Clinical Medical College of Guangdong Medical University, Huizhou, 516001, People's Republic of China; 2 Department of Burn Surgery, Huizhou Municipal Central Hospital, Huizhou, 516001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chunli Xue, Department of Burn Surgery, Huizhou Municipal Central Hospital, No. 41, Eiling North Road, Huicheng District, Huizhou, 516001, People's Republic of China, Email Background: lncRNA β‐1,3‐galactosyltransferase 5‐AS1 (B3GALT5-AS1) plays a vital regulatory role in colon and gastric cancers. However, the biological functions and regulatory mechanisms of B3GALT5-AS1 in keloid progression remain unknown. This study aims to investigate the molecular mechanisms in the B3GALT5-AS1-regulated keloid proliferation and invasion. Methods: Secondary mining of the lncRNA sequencing data from GSE158395 was conducted to screen differentially expressed lncRNAs between keloid and normal tissues. MTT, cell migration and invasion assays were performed to detect the effects of B3GALT5-AS1 on keloid fibroblasts (KFs) proliferation and metastasis. The extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were also determined to evaluate glycolysis in KFs. RNA pull-down and RNA-protein immunoprecipitation assays were used to confirm the interaction between B3GALT5-AS1 and Hu-Antigen R (HuR). Further ubiquitination and rescue experiments were performed to elucidate the regulatory relationship between B3GALT5-AS1 and HuR. Results: B3GALT5-AS1 was significantly down-regulated in keloid tissues and fibroblasts. B3GALT5-AS1 overexpression significantly inhibited KFs proliferation, glycolysis, invasion, and migration and promoted cell apoptosis, whereas silencing B3GALT5-AS1 inhibited these effects. Moreover, B3GALT5-AS1 binds to HuRand reduces its stability through β-Transducin repeats-containing protein 1 (β-Trcp1)-mediated ubiquitination. Overexpression of HuR reversed the inhibition of B3GALT5-AS1 on cell proliferation, migration, and invasion in KFs, where glycolysis pathway was involved. Conclusion: Our findings illustrate that B3GALT5-AS1 has great effect on inhibition of keloid formation, which provides a potential target for keloid therapy. Keywords: B3GALT5-AS1, keloid, fibroblast, HuR, β-Trcp1 Keloid is a highly recurrent benign skin tumor resulting from excessive fibroblast proliferation and progressive extracellular matrix deposition. 1 Although several common strategies, including surgical excision, radiation therapy, steroid injections, and compression therapy, have been applied for preventing and treating keloid, they have been proven to be limited effectiveness and easy relapse. 2,3 Therefore, more attention should be paid to explore the pathogenic mechanisms underlying keloid progression and developing innovative therapeutic strategies. Long non-coding RNAs (lncRNAs) are a heterogeneous population of RNA molecules that are longer than 200 nucleotides but lack functional open reading frames. 4 Numerous lncRNAs play regulatory effects in diverse biological processes, such as gene transcription, post-transcription, and epigenetic modification, due to the advances of high-throughput sequencing and bioinformatics technologies. 5,6 Moreover, accumulating evidence demonstrated that the aberrant lncRNA expression had been associated with the pathological development of keloid disorder. 7,8 lncRNA H19 up-regulation the proliferation and metastasis of fibroblasts by altering the miR-29a and COL1A1 expression. 9 Moreover, the high HOXA11-AS expression was observed in keloid tissues and fibroblasts, inhibiting cell apoptosis and facilitating angiogenesis via the miR-124-3p/TGFβR1 axis. 10 However, whether other potential lncRNAs can regulate keloid formation remains unknown; thus, ongoing research in the regulatory mechanisms of lncRNAs in keloid pathogenesis is essential for developing diagnostic targets for keloid therapy. In this study, GEO dataset was used to analyze differentially expressed lncRNAs in keloid tissues compared to normal tissues. A low level of B3GALT5-AS1 was found in keloid tissues, but its function has not been reported yet. We evaluated cell proliferation, invasion, and migration in keloid fibroblasts (KFs) after overexpression or knockdown of B3GALT5-AS1. We found that B3GALT5-AS1 promoted the binding of β-Trcp1 to HuR, leading to the ubiquitination and degradation of HuR. This results in inhibition of c -Abstract Truncated-

HOXA11-AS Regulates NIPAL3 Via Hsa-miRNA-19a-3p, Hsa-miR-141-3p and Hsa-miR-140-5p in Keloid Fibroblast: Bioinformatic Analysis and in Vitro Validation

Construction of a HOXA11-AS-Interact Ed Network in Keloid Fibroblasts Using Integrated Bioinformatic Analysis and in Vitro Validation

Comprehensive Analysis of Circular RNA Expression in Cerna Networks and Identification of the Effects of Hsa_circ_0006867 in Keloid Dermal Fibroblasts

Identification of potential therapeutic target SPP1 and related RNA regulatory pathway in keloid based on bioinformatics analysis

Detection and Analysis of Long Noncoding RNA Expression Profiles Related to Epithelial-Mesenchymal Transition in Keloids

LINC00937 suppresses keloid fibroblast proliferation and extracellular matrix deposition by targeting the miR-28-5p/MC1R axis

MicroRNAs Associated with Keloids Identified by Microarray Analysis and In Vitro Experiments

STAT3‐induced lncRNA GNAS‐AS1 accelerates keloid formation by mediating the miR‐196a‐5p/CXCL12/STAT3 axis in a feedback loop

Long Non-Coding RNA Expression Profiling in the Lesional Tissue and Derived Fibroblasts of Keloid

MiR-181a Targets PHLPP2 to Augment AKT Signaling and Regulate Proliferation and Apoptosis in Human Keloid Fibroblasts.

Identifying Mirnas Associated with the Progression of Keloid Through Mrna-Mirna Network Analysis and Validating the Targets of Mir-29A-3p in Keloid Fibroblasts

Long Non-Coding RNA Uc003jox.1 Promotes Keloid Fibroblast Proliferation and Invasion Through Activating the PI3K/AKT Signaling Pathway.

Integrated bioinformatics analysis of core regulatory elements involved in keloid formation

Identification and validation of HOXD3 and UNC5C as molecular signatures in keloid based on weighted gene co-expression network analysis

Genome-wide Analysis of Dysregulated RNA-binding Proteins and Alternative Splicing Genes in Keloid

Underlying Genes and Molecular Mechanism of Keloids Investigated by Integrated Bioinformatics Analysis

Aberrantly Expressed Small Noncoding RNAome in Keloid Skin Tissue

Adipose-derived mesenchymal stem cells-sourced exosomal microRNA-7846-3p suppresses proliferation and pro-angiogenic role of keloid fibroblasts by suppressing neuropilin 2

miRSNP rs188493331: A key player in genetic control of microRNA‐induced pathway activation in hypertrophic scars and keloids

Secondary data mining of GEO database for long non-coding RNA and Competing endogenous RNA network in keloid-prone individuals

Long Non-Coding RNA B3GALT5-AS1 Suppresses Keloid Progression by Regulating the β-Trcp1-Mediated Ubiquitination of HuR